This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Microsoft, Activision execs won’t face depositions from private plaintiffs until after US FTC action is resolved, judge says

By Michael Acton ( June 1, 2023, 18:06 GMT | Insight) -- Microsoft and Activision Blizzard executives won’t have to sit for depositions in a private legal challenge to their deal until after a US Federal Trade Commission challenge to the acquisition is resolved, the California federal judge in the case said today. Despite pushback from lawyers for the plaintiffs — a proposed class of video game players — US District Judge Jacqueline Scott Corley said it made no sense to require individuals including Activision CEO Bobby Kotick to sit for depositions while the status of the deal remains unclear. Microsoft and Activision Blizzard executives won’t have to sit for depositions in a private legal challenge to their deal until after a US Federal Trade Commission challenge to the acquisition is resolved, the California federal judge in the case said today....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login